Hurst's the Heart, 12th Edition / Edition 12

Hurst's the Heart, 12th Edition / Edition 12

by Valentin Fuster
     
 

ISBN-10: 0071478868

ISBN-13: 9780071478861

Pub. Date: 12/26/2007

Publisher: McGraw-Hill Companies, The

Along with a strong focus on patient care the new Hurst's The Heart includes a new look and organization. Each chapter has been systematically overhauled with an emphasis on streamlining the content for a focused presentation of the LATEST THERAPEUTIC STRATEGIES and the EVIDENCE-BASED DATA that support them. CLINICAL GUIDELINES are included to equip you with…  See more details below

Overview

Along with a strong focus on patient care the new Hurst's The Heart includes a new look and organization. Each chapter has been systematically overhauled with an emphasis on streamlining the content for a focused presentation of the LATEST THERAPEUTIC STRATEGIES and the EVIDENCE-BASED DATA that support them. CLINICAL GUIDELINES are included to equip you with the critical information for optimal patient care in an increasingly time-pressured, cost/benefit environment.

The major changes that await you in the tenth edition of The Heart start with the dynamic new author team. Led by Valentin Fuster, Wayne Alexander and Robert A. O'Rourke, the editors have assembled an international group of thought leaders in cardiology who are distinguished not only by their academic prowess, but also by their clinical expertise. They know the latest treatment approaches because they practice them daily and document them here for you with precision.

The New 10th Edition of Hurst's The Heart is dramatically revised, and uniquely focused on the evolving demands of your daily practice:


    WHAT'S NEW in the Tenth Edition
  • Expanded coverage of molecular biology of blood vessels and myocardium
  • More information on testing modalities—especially those related to nuclear myocardial perfusion imaging, MRI and PET
  • New emphasis on managing heart failure, including interventional techniques and new drug therapy strategies
  • Additional chapters on the biology of coronary heart disease
  • Expanded sections related to prevention, diagnosis and treatment
  • More emphasis on integrating the science of cardiac care with treatment
  • Easy-to-reference, evidence-based practice guidelines where appropriate
  • New insight on the human genome project and its implications
  • Techniques for clinical evaluation of the patient
  • Late-breaking reports on clinical trials
  • Heart disease in diabetics
  • New sections on nonsurgical interventions in cardial and peripheral vascular disease

About the Author:
NEW AUTHOR TEAM:
VALENTIN FUSTER, M.D. Ph.D
Director, The Zena and Michael A. Wiener Cardiovascular Institute Richard Gorlin, M.D./Heart Research Foundation Professor of Cardiology, Vice Chairman, Department of Medicine, The Mount Sinai Medical Center, New York, New York
R. WAYNE ALEXANDER, M.D., Ph.D.
R. Bruce Logue Professor and Chair Department of Medicine Emory University School of Medicine Atlanta, Georgia
ROBERT A. O'ROURKE, M.D.
Charles Conrad Brown Distinguished Professor in Cardiovascular Disease University of Texas Health Science Center at San Antonio San Antonio, Texas
ROBERT ROBERTS, M.D.
Don W. Chapman Professor of Medicine and Chief of Cardiology Professor of Cell Biology, Molecular Physiology and Biophysics Director, Bugher Foundation Center for Molecular Biology in the Cardiovascular System Baylor College of Medicine Director, Specialized Center for Research in Heart Failure Houston, Texas
SPENCER B. KING III, M.D.
Professor of Medicine (Cardiology) Emory University School of Medicine Director, Interventional Cardiology Emory University Hospital Atlanta, Georgia
HEIN J.J. WELLENS, M.D.
Professor and Chairman of the Department of Cardiology Academic Hospital Maastricht Maastricht, The

Read More

Product Details

ISBN-13:
9780071478861
Publisher:
McGraw-Hill Companies, The
Publication date:
12/26/2007
Edition description:
Older Edition
Pages:
2200
Product dimensions:
8.80(w) x 11.30(h) x 3.31(d)

Related Subjects

Table of Contents

Part 1
Cardiovascular Disease: Past, Present & Future
1 A HISTORY OF THE HEART
2 THE BURDEN OF INCREASING WORLDWIDE CARDIOVASCULAR DISEASE Part II FOUNDATIONS OF CARDIOVASCULAR MEDICINE
3 FUNCTIONAL ANATOMY OF THE HEART
4 NORMAL PHYSIOLOGY OF THE CARDIOVASCULAR SYSTEM
5 PRINCIPLES OF MOLECULAR CARDIOLOGY
6 MOLECULAR AND CELLULAR BIOLOGY OF THE NORMAL, HYPERTROPHIED, AND FAILING HEART
7 BIOLOGY OF THE VESSEL WALL
8 MOLECULAR DEVELOPMENT OF THE HEART AND VASCULATURE
9 GENETIC BASIS FOR CARDIOVASCULAR DISEASE
10 Tissue Regeneration of CARDIOVASCULAR System and the Stem Cells Part 3
EVALUATION OF THE PATIENT
11 THE HISTORY, PHYSICAL EXAMINATION, AND CARDIAC AUSCULTATION
12 THE RESTING ELECTROCARDIOGRAM
13. THE ELECTROCARDIOGRAM IN ACUTE MYOCARDIAL INFARCTION
14. ECG EXERCISE TESTING
15 THE CHEST ROENTGENOGRAM AND CARDIAC
16 THE ECHOCARDIOGRAM
17 CARDIAC CATHETERIZATION, CARDIAC ANGIOGRAPHY, AND CORONARY BLOOD FLOW AND PRESSURE MEASUREMENTS
18 CORONARY ULTRASOUND IMAGING
19 NUCLEAR CARDIOLOGY
20 COMPUTED TOMOGRAPHY OF THE HEART
21 MAGNETIC RESONANCE IMAGING OF THE HEART
22 MAGNETIC RESONANCE IMAGING AND COMPUTED TOMOGRAPHY OF THE VASCULAR SYSTEM
23 POSITRON EMISSION TOMOGRAPHY Part 4
HEART FAILURE
24. PATHOPHYSIOLOGY OF HEART FAILURE
25. EPIDEMOLOGY AND DIAGNOSIS OF HEART FAILURE
26 DIAGNOSIS AND MANAGEMENT OF HEART FAILURE
27 SURGICAL TREATMENT OF HEART FAILURE, CARDIAC TRANSPLANTATION, AND MECHANICAL VENTRICULAR SUPPORT Part 5
CARDIOMYOPATHY AND SPECIFIC HEART MUSCLEDISEASES
28 CLASSIFICATION OF CARDIOMYOPATHIES
29 DILATED CARDIOMYOPATHIES
30 HYPERTROPHIC CARDIOMYOPATHY
31. ATHLETE'S HEART
32 RESTRICTIVE, OBLITERATIVE, AND INFILTRATIVE CARDIOMYOPATHIES
33 MYOCARDITIS AND SPECIFIC CARDIOMYOPATHIES—Alcohol, HIV, Endocrine disease Part 6
RHYTHM AND CONDUCTION DISORDERS
34 MECHANISMS OF CARDIAC ARRHYTHMIAS AND CONDUCTION DISTURBANCES
35 APPROACH TO THE PATIENT WITH CARDIAC ARRHYTHMIAS
36 ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND ATRIAL TACHYCARDIA
37 SUPRAVENTRICULAR TACHYCARDIA: AV NODE REENTRY AND WOLFF-PARKINSON-WHITE SYNDROME
38 VENTRICULAR ARRHYTHMIAS
39 BRADYARRHYTHMIAS AND PACEMAKERS
40 LONG-TERM CONTINUOUS ELECTROCARDIOGRAPHIC RECORDING
41 TECHNIQUES OF ELECTROPHYSIOLOGIC EVALUATION
42 ANTIARRHYTHMIC DRUGS
43 TREATMENT OF CARDIAC ARRHYTHMIAS WITH CATHETER-ABLATIVE TECHNIQUES
44 INDICATIONS AND TECHNIQUES OF ELECTRICAL CARDIOVERSION
45 THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
46 PEDIATRIC ARRHYTHMIAS Part 7
SYNCOPE, SUDDEN DEATH, AND CARDIOPULMONARY RESUSCITATION
47 DIAGNOSIS AND MANAGEMENT OF SYNCOPE
48 SUDDEN CARDIAC DEATH
49 CARDIOPULMONARY RESUSCITATION AND THE SUBSEQUENT MANAGEMENT OF THE PATIENT Part 8
CORONARY HEART DISEASE Section 1: Pathophysiology & Prevention of CHD
50 Overall Prev Strategies of CHD
51 ATHEROTHROMBOSIS AND Inflammation
52 CORONARY THROMBOSIS: LOCAL AND SYSTEMIC FACTORS
53 CORONARY BLOOD FLOW AND MYOCARDIAL ISCHEMIA
54 NONATHEROSCLEROTIC CORONARY HEART DISEASE
55 DEFINITIONS OF ACUTE CORONARY SYNDROMES & Clinical Implications
56 PATHOLOGY OF MYOCARDIAL ISCHEMIA, INFARCTION, REPERFUSION, AND SUDDEN DEATH
57 THE PATHOLOGIC AND BIOCHEMICAL BASIS FOR MYOCARDIAL ISCHEMIA AND REPERFUSION INJURY Section 2: Clinical Presentation, Dx Eval & Managment
58 UNSTABLE ANGINA AND NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: CLINICAL PRESENTATION, DIAGNOSTIC EVALUATION
59 ST-SEGMENT-ELEVATION MYOCARDIAL INFARCTION:CLINICAL PRESENTATION and DIAGNOSTIC EVALUATION
60 Pharmacologic Therapy
61 PERCUTANEOUS CORONARY INTERVENTION
62 MECHANICAL INTERVENTIONS IN ACUTE MYOCARDIAL INFARCTION
63 DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
64 CORONARY BYPASS SURGERY
65 MANAGEMENT OF THE PATIENT AFTER CARDIAC SURGERY
66 REHABILITATION OF THE PATIENT WITH CORONARYH EART DISEASE Part 9
SYSTEMIC ARTERIAL HYPERTENSION
67 Dx & Tx of HYPERTENSION a. EPIDEMIOLOGY b. PATHOPHYSIOLOGY Part 10
CARDIOPULMONARY DISEASE
68 PULMONARY HYPERTENSION Ch. 68.5
69 PULMONARY EMBOLISM
70 CHRONIC COR PULMONALE Part 11
VALVULAR HEART DISEASE
71 ACUTE RHEUMATIC FEVER
72 AORTIC VALVE DISEASE
73 MITRAL VALVE DISEASE & Regurgitation Including Mitral Valve Prolapse
74 MITRAL VALVE Stenosis
75 TRICUSPID VALVE, PULMONIC VALVE, AND MULTIVALVULAR DISEASE
76 CLINICAL PERFORMANCE OF PROSTHETIC HEART VALVES
77 ANTITHROMBOTIC THERAPY FOR VALVULAR HEART DISEASE Part 12
CONGENITAL HEART DISEASE
78 CARDIOVASCULAR DISEASES DUE TO GENETIC ABNORMALITIES
79 THE PATHOLOGY, PATHOPHYSIOLOGY, RECOGNITION, ANDTREATMENT OF CONGENITAL HEART DISEASE
80 CONGENITAL HEART DISEASE IN ADULTS Part 14
PERICARDIAL DISEASES AND ENDOCARDITIS
81 DISEASES OF THE PERICARDIUM
82 INFECTIVE ENDOCARDITIS Part 15
ANESTHESIA, SURGERY, AND THE HEART
83 PERIOPERATIVE EVALUATION AND MANAGEMENT OF PATIENTS WITH KNOWN OR SUSPECTED CARDIOVASCULAR DISEASE WHO UNDERGO NONCARDIAC SURGERY
84 ANESTHESIA AND THE PATIENT WITH CARDIOVASCULAR DISEASE Part 16
MISCELLANEOUS CONDITIONS AND CARDIOVASCULAR DISEASE
85 THE CONNECTIVE TISSUE DISEASES AND THE CARDIOVASCULAR SYSTEM
86 NEOPLASTIC HEART DISEASE
87 DIABETES AND CARDIOVASCULAR DISEASE
88 THE METABOLIC SYNDROME, OBESITY, AND DIET
89 AIDS AND THE CARDIOVASCULAR SYSTEM
90 EFFECT OF NONCARDIAC DRUGS, ELECTRICITY, POISONS, AND RADIATION ON THE HEART
91 ADVERSE CARDIOVASCULAR DRUG INTERACTIONS AND COMPLICATIONS
92 EFFECTS OF MOOD AND ANXIETY DISORDERS ON THE CARDIOVASCULAR SYSTEM
93 HEART DISEASE AND PREGNANCY
94 TRAUMATIC HEART DISEASE
95 THE HEART AND KIDNEY DISEASE
96 EXERCISE AND THE CARDIOVASCULAR SYSTEM
97 CARDIOVASCULAR AGING IN THE ABSENCE OF CLINICAL DISEASE AND THERAPEUTIC CONSIDERATIONS FOR OLDER PATIENTSWITH CLINICAL CARDIOVASCULAR DISEASES
98 WOMEN AND CORONARY ARTERY DISEASE Part 17
DISEASES OF THE GREAT VESSELS AND PERIPHERALVESSELS
99 DISEASES OF THE AORTA
100 CEREBROVASCULAR DISEASE AND NEUROLOGIC MANIFESTATIONS OF HEART DISEASE
101 THE NONSURGICAL APPROACH TO CAROTID DISEASE
102 DIAGNOSIS AND MANAGEMENT OF DISEASES OF THE PERIPHERAL ARTERIES AND VEINS
103 SURGICAL TREATMENT OF CAROTID AND PERIPHERAL VASCULAR DISEASE
104 ADVANCES IN THE MINIMALLY INVASIVE TREATMENT OF PERIPHERAL VASCULAR DISEASE Part 18
SOCIAL ISSUES AND CARDIOVASCULAR DISEASE
105 COST-EFFECTIVE STRATEGIES IN CARDIOLOGY
106 INSURANCE ISSUES IN PATIENTS WITH HEART DISEASE
107 CLINICAL PRACTICE GUIDELINES IN CARDIOVASCULAR DISEASE
108 BEHAVIORAL MEDICINE IN THE TREATMENT OF HEART DISEASE
109 COMPLEMENTARY AND ALTERNATIVE MEDICAL THERAPY IN CARDIOVASCULAR CARE

EDITORS:

Valentin Fuster MD, PhD, FACC, FAHA

Robert Gorlin, MD / Heart Research Foundation

Director, Mount Sinai Heart

Director, The Zena and Michael A. Wiener Cardiovascular Institute

and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health

The Mount Sinai Medical Center

New York, NY

Robert A. O'Rourke, MD, MACC, MACP, FAHA,

Distinguished Professor of Medicine, Emeritus

University of Texas Health Science Center at San Antonio

San Antonio, TX

Richard A. Walsh, MD, FACC, FAHA,

John H. Hord Professor

Chair, Department of Medicine

Case Western Reserve University

Physician-in-Chief

University Hospitals of Cleveland

Cleveland, OH

Philip Poole-Wilson, MD, FRCP. FESC. FAAC. FMedSci,

Professor of Cardiology

British Heart Foundation

Simon Marks Chair of Cardiology

Head of Cardiac Medicine

National Heart and Lung Institute

Faculty of Medicine

Imperial College, London, United Kingdom

Honorary Consultant, Royal Brompton and Harefield NHS Trust

London, UK

ASSOCIATE EDITORS:

Spencer B. King III, MD, MACC, FAHA,

Professor of Medicine, Emeritus

Emory University School of Medicine

Director of Interventional Cardiology

Fuqua Chair of Interventional Cardiology

Fuqua Heart Center

Piedmont Hospital

Atlanta, GA

Robert Roberts, MD, FRCP(C), FACC, FAHA

President and CEO

University of Ottawa Heart Institute

Director, The Ruddy Canadian Cardiovascular Genetics Centre

Ottawa, Ontario, Canada

Ira S. Nash, MD, FACC, FAHA,

Vice Chairman for Veterans Affairs

Associate Professor of Medicine

Samuel Bronfman Department of Medicine

Mount Sinai School of Medicine

Chief of Internal Medicine

James J. Peters VA Medical Center

New York, NY

Eric N. Prystowsky, MD, FACC, FAHA,

Consulting Professor of Medicine

Duke University Medical Center

Director, Clinical Electrophysiology Laboratory

St. Vincent Hospital

Indianapolis, IN

Read More

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >